State of Delaware v. Purdue Pharma L.P. ( 2019 )


Menu:
  • IN THE SUPERIOR COURT OF THE STATE OF DELAWARE
    STATE OF DELAWARE, ex rel.
    KATHLEEN JENNINGS, Attorney
    General of the State of Delaware,
    Plaintiff, C.A. No. N18C-01-223 MMJ CCLD
    Vv.
    PURDUE PHARMA L.P.; PURDUE
    PHARMA INC.; THE PURDUE
    FREDERICK COMPANY; ENDO
    HEALTH SOLUTIONS INC.;
    ENDO PHARMACEUTICALS INC.;
    MCKESSON CORPORATION;
    CARDINAL HEALTH INC.;
    AMERISOURCEBERGEN
    CORPORATION; ANDA
    PHARMACEUTICALS, INC.; H.D.
    SMITH, LLC; CVS HEALTH
    CORPORATION; and WALGREENS
    BOOTS ALLIANCE, INC.,
    Defendants.
    we Oe A ae Oe ae ae Oem se I nm EE ——E nn «En IE EM OE
    Submitted: November 25, 2019
    Decided: December 4, 2019
    ORDER DENYING LEAVE TO APPEAL
    FROM INTERLOCUTORY ORDER
    (1) Plaintiff the State of Delaware has moved for an order certifying an
    interlocutory appeal to the Delaware Supreme Court. The determination of whether
    to certify an interlocutory appeal lies within the discretion of the Court and is
    analyzed under the criteria set forth in Supreme Court Rule 42(b).' An interlocutory
    appeal will not be certified unless the Court finds that its decision: (1) determines a
    substantial issue; (2) establishes a legal right; and (3) satisfies one of the five criteria
    set forth in Rule 42(b)(i)-(v). Under Rule 42(b)(i), the Court may look to the criteria
    established by Rule 41.
    (2) In this action, the State seeks to recover damages allegedly resulting
    from manufacturers’, distributors’, and pharmacies’ misconduct relating to
    prescription opiods. This Court originally dismissed the State’s claims against
    Defendant Walgreens, without prejudice, requiring that the State file an Affidavit of
    Merit pursuant to 
    18 Del. C
    . § 6853(a)(1). An Affidavit of Merit was filed under
    seal and reviewed by the Court. The Court found that the Affidavit was insufficient
    and granted the State leave to amend. The Court found that the Affidavit must
    include examples of specific injuries to individuals, and the proximate cause link
    between any breaches of pharmaceutical duties and individual patients. It was not
    enough that the State allege medical negligence in its role as parens patriae, on
    behalf of its citizens in general.
    (3) The State filed a Motion for Reargument, which was denied on September
    25, 2019.
    ‘See, e.g., Tortuga Cas. Co. v. Nat'l Fire Ins. Co. of Pittsburgh, 
    1991 WL 247813
    , at *2 (Del.);
    State v. Superior Court, 
    141 A.2d 468
    , 471 (Del. 1968).
    (4) The State argues that interlocutory appeal pursuant to Supreme Court
    Rule 42(b) is justified because the Court’s decision: relates to the merits of the case
    and determines a substantial issue of material importance; involves an issue of first
    impression in Delaware; relates to statutory construction; and an interlocutory order
    may resolve a conflict between trial courts.
    (4) Walgreens opposes certification of the interlocutory appeal. Walgreens
    argues that: the application is untimely; the State has not shown that the benefits of
    interlocutory review outweigh the costs; and the State’s application fails to satisfy
    Rule 42(b)(iii).
    (5) The Court finds that its decision determines a substantial issue of
    material importance; involves a question of law resolved for the first time in
    Delaware;? and relates to statutory construction.* The Court does not find that there
    is a conflict between trial courts requiring interlocutory review.’ Rather, the finding
    that the Affidavit of Merit was insufficient addresses a narrow issue not previously
    considered in other decisions, primarily because in a typical medical negligence
    *Supr. Ct. R. 42(b)(i).
    3Supr, Ct. R. 42(b)(iii)(A).
    4Supr. Ct. R. 42(b)(iii)(C).
    SSupr. Ct. R. 42(b)(iii)(B).
    case, the complaint clearly states the identity of the allegedly injured individual
    patient.
    (6) The Court finds that interlocutory review in this case will not
    substantially reduce further litigation and otherwise serve considerations of justice.®
    There is presently pending another motion filed by the State, pursuant to Rule 54(b),
    challenging the Court’s previous ruling that the State may only proceed against
    Walgreens through a health-care negligence claim. Additionally, the State has filed
    a Supplemental Affidavit of Merit. The Court has not yet had an opportunity to
    review the Supplemental Affidavit for sufficiency.
    THEREFORE, the State has failed to demonstrate: that the likely benefits of
    interlocutory review at this time are not outweighed by the probable costs; and that
    interlocutory review is in the interests of justice.’ The Application for Certification
    of an Interlocutory Appeal is hereby DENIED.
    IT IS SO ORDERED.
    The Hénorable Mary M. Johnston
    °See Supr. Ct. R. 42(b)(iii).
    7Supr. Ct. R. 42(b)(Gii)(ED.
    

Document Info

Docket Number: N18C-01-223 MMJ CCLD

Judges: Johnston J.

Filed Date: 12/4/2019

Precedential Status: Precedential

Modified Date: 12/4/2019